Welcome to the New Nuclear Medicine Technologist Section, providing you access to everything you need on the SNMMI website in one place.
Make your plans to attend the SNMMI 2017 Annual Meeting—the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. SNMMI's marquee event provides you with an in-depth view of the latest technologies and research in the field.
The SNMMI Annual Meeting also offers special targeted programming, and great opportunities for you to reconnect with your peers from around the globe, including:
Myocardial Perfusion Imaging 2016: Quality, Safety, and Dose Optimization offers comprehensive coverage of myocardial perfusion imaging, with particular focus on ways to improve quality, increase safety, and reduce radiation burden. Written by experienced nuclear medicine technologists and physicians, this is an easy-to-use reference that will give new insights to even the most tenured technologists.
Table of Contents
|Chapter 1. Introduction and Overview
Chapter 2. Patient Preparation and Education
Chapter 3. Stress Testing
Chapter 4. Radiopharmaceuticals
Chapter 5. Quality Control
Chapter 6. Imaging Protocols
|Chapter 7. Acquisition
Chapter 8. Processing
Chapter 9. Artifacts
Chapter 10. Basic Interpretation
Chapter 11. Future of Myocardial Perfusion Imaging
SNMMI educational programs are designed to meet the professional development needs of technologists in the field of nuclear medicine and molecular imaging, as well as providing them with continuing education credit opportunities. SNMMI is an ARRT-recognized conitinuing education mechanism (RCEEMs) provider through the Society's Verification Of Involvement in Continuing Education (VOICE) program.
Introducing a new member-benefit. Stay on top of the latest trends and advancements in the profession with quarterly technologist-focused webinars—free for SNMMI-TS members.
The PET Online Review Workshop is designed to help prepare technologists for the NMTCB's PET Exam. Following the NMTCB's content outline, the workshop offers a comprehensive review of both PET and PET/CT.
The spectrum of responsibilities for a nuclear medicine technologist varies widely across the United States. Practice components presented in this document provide a basis for establishing the areas of knowledge and performance for the nuclear medicine technologist. The nuclear medicine technologist must be in compliance with all federal, state, and institutional guidelines, including proper documentation of initial and continued competency in those practices and activities.
Continuing education is a necessary component in maintaining the skills required to perform all duties and tasks of the nuclear medicine technologist in this ever-evolving field.
The Nuclear Medicine Technologist Scope of Practice and Performance Standards document is intended to set forth the standards in important areas of the nuclear medicine technologist’s responsibilities. It may not cover all areas which may present themselves in actual practice. These standards do not supersede the judgment of the individual nuclear medicine technologist and other healthcare professionals serving the patient in light of all of the facts of the individual case. THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING AND THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING TECHNOLOGIST SECTION DISCLAIM ALL LIABILITY ARISING FROM USE OF THESE DOCUMENTS.
NMT Scope of Practice and Performance Standards - Approved September 2016
Visit SNMMI's Career Center.
The nuclear medicine and molecular imaging technologists are highly specialized healthcare professionals who works closely with the nuclear medicine physician. Some of the technologist’s primary responsibilities are to: Prepare and administer radioactive chemical compounds, known as radiopharmaceuticals and to administer adjunctive medications in order to perform patient imaging procedures using sophisticated instrumentation; Process data and enhance digital images using advanced computer technology; Provide images, data analysis, and patient information to the physician for diagnostic interpretation; and Evaluate new procedures for appropriateness in specific clinical settings and patient populations.
The Society of Nuclear Medicine and Molecular Imaging Technologist Section as part of the SNMMI, is constantly striving to make a difference in the way nuclear medicine and molecular imaging technologists receive academic and continuing education as well as information concerning new procedures, technologies and equipment. Research has been a vital part of SNMMI-TS activities for many years, as has monitoring federal regulation and influencing decisions that affect the practice of nuclear medicine.
In addition to providing discussion forums and publishing journals, newsletters and books, SNMMI-TS also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new scientific advances. The activities of the SNMMI-TS National Council of Representatives, volunteer committee members, and staff focus on improving the quality of care for the patients served by technologists around the world.
Today, information is received through a variety of media. What social media excels at is providing immediacy and a network of colleagues. It’s evident that these channels provide valuable information, as SNMMI’s Facebook page now has more than 12,000 likes, and the SNMMI LinkedIn group has more than 11,000 members!
Dirk (Dik) J. Kwekkeboom, MD, PhD, professor of nuclear medicine at Erasmus Univeristy in Rotterdam, The Netherlands, passed away March 8, 2017. An SNMMI member since 1998, he was considered one of Europe’s foremost experts on peptide receptor radiotherapy and was a frequent international speaker on neuroendocrine tumor imaging and lutetium-177 octreotate therapy.
The March 2017 issue of "The Journal of Nuclear Medicine Technology" is now available.
The featured clinical investigation article of the March 2017 issue of "The Journal of Nuclear Medicine" demonstrates that the PET radiotracer fluciclovine (fluorine-18; F-18) can help guide and monitor targeted treatment for recurrent prostate cancer, allowing for individualized, targeted therapy.